Natural killer cells in antitumour adoptive cell immunotherapy

TJ Laskowski, A Biederstädt, K Rezvani - Nature Reviews Cancer, 2022 - nature.com
Natural killer (NK) cells comprise a unique population of innate lymphoid cells endowed with
intrinsic abilities to identify and eliminate virally infected cells and tumour cells. Possessing …

The emerging roles of SUMOylation in the tumor microenvironment and therapeutic implications

Y Gu, Y Fang, X Wu, T Xu, T Hu, Y Xu, P Ma… - … Hematology & Oncology, 2023 - Springer
Tumor initiation, progression, and response to therapies depend to a great extent on
interactions between malignant cells and the tumor microenvironment (TME), which denotes …

Impact of the selective A2AR and A2BR dual antagonist AB928/etrumadenant on CAR T cell function

M Seifert, MR Benmebarek, D Briukhovetska… - British Journal of …, 2022 - nature.com
Background Chimeric antigen receptor (CAR) T cell therapy has been successfully
translated to clinical practice for the treatment of B cell malignancies. The suppressive …

[HTML][HTML] Hepatocellular carcinoma-derived FOXO1 inhibits tumor progression by suppressing IL-6 secretion from macrophages

X Cui, H Zhao, S Wei, Q Du, K Dong, Y Yan, DA Geller - Neoplasia, 2023 - Elsevier
Tumor heterogeneity dominates tumor biological behavior and shapes the tumor
microenvironment. However, the mechanisms of tumor genetic features modulate immunity …

Mechanisms and functions of SUMOylation in health and disease: a review focusing on immune cells

CH Huang, TT Yang, KI Lin - Journal of Biomedical Science, 2024 - Springer
SUMOylation, which is a type of post-translational modification that involves covalent
conjugation of small ubiquitin-like modifier (SUMO) proteins to target substrates, regulates …

SUMOylation inhibitor TAK-981 (subasumstat) synergizes with 5-azacytidine in preclinical models of acute myeloid leukemia

L Gabellier, M De Toledo, M Chakraborty… - …, 2023 - pmc.ncbi.nlm.nih.gov
Acute myeloid leukemias (AML) are severe hematomalignancies with dismal prognosis. The
post-translational modification SUMOylation plays key roles in leukemogenesis and AML …

Paradoxes of cellular SUMOylation regulation: a role of biomolecular condensates?

X Cheng, W Yang, W Lin, F Mei, G Schulte - Pharmacological Reviews, 2023 - Elsevier
Protein SUMOylation is a major post-translational modification essential for maintaining
cellular homeostasis. SUMOylation has long been associated with stress responses as a …

Nilotinib boosts the efficacy of anti-PDL1 therapy in colorectal cancer by restoring the expression of MHC-I

H Dong, C Wen, L He, J Zhang, N Xiang… - Journal of Translational …, 2024 - Springer
Background Although immune checkpoint inhibitors (ICIs) have revolutionized the
landscape of cancer treatment, only a minority of colorectal cancer (CRC) patients respond …

Circular RNA-encoded oncogenic PIAS1 variant blocks immunogenic ferroptosis by modulating the balance between SUMOylation and phosphorylation of STAT1

X Zang, XY He, CM Xiao, Q Lin, MY Wang, CY Liu… - Molecular Cancer, 2024 - Springer
Background The clinical response rate to immune checkpoint blockade (ICB) therapy in
melanoma remains low, despite its widespread use. Circular non-coding RNAs (circRNAs) …

SUMOylation of RNF146 results in Axin degradation and activation of Wnt/β-catenin signaling to promote the progression of hepatocellular carcinoma

W Li, Q Han, Y Zhu, Y Zhou, J Zhang, W Wu, Y Li, L Liu… - Oncogene, 2023 - nature.com
Aberrant SUMOylation contributes to the progression of hepatocellular carcinoma (HCC), yet
the molecular mechanisms have not been well elucidated. RING-type E3 ubiquitin ligase …